Advertisement
Screener

Korro Bio, Inc. (KRRO) Form D

Korro Bio, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2020-07-27: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2020-07-20; Total offering amount $42,301,944.
  • 2019-07-23: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-07-17; Total offering amount $61,999,366.
  • 2017-04-14: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2017-03-30; Total offering amount $32,000,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2020-07-27Rule 506(b)Equity2020-07-20$42,301,944$42,301,944$018
2019-07-23Rule 506(b)Equity2019-07-17$61,999,366$61,999,366$080
2017-04-14Rule 506(b)Equity2017-03-30$32,000,000$32,000,000$090

Similar stocks

Stock NameCountryMarket CapPE Ratio
Atrium Therapeutics, Inc. (RNA)United States$0.140B
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
Annexon, Inc. (ANNX)United States$0.147B-4.22
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
MEDICINOVA INC (MNOV)United States$0.130B-6.04
IMMUNIC, INC. (IMUX)United States$0.127B-1.88